Login
$HRTX
$0.29 +$0.01 (3.41%) After hours

Ownership

13F as of Q2 2026 · 190.9M shares outstanding

Who owns HRTX?

By type of holder
Institutions 69.9% Insiders 5.7% Everyone else 24.4%
Concentration Top 10 holders own 65.1%
Rubric Capital Management LP 15.7% · David Rosen 15.7%
Institutional ownership
69.9%
-12.3 pts vs last qtr
Institutional holders
162
-5 vs last qtr
Net shares bought
−23.5M
by institutions in Q2 2026
New / sold out
22 / 27
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Marshall Wace, LLP NEW +2.4M
  • Qube Research & Technologies Ltd +990.7K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Orbimed Advisors LLC SOLD OUT −9.8M
  • Palisade Capital Management, LP SOLD OUT −6.1M

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for HERON THERAPEUTICS, INC. /DE/ in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+339.6%
+17.88% a year
Each share's claim on the business
−77.3%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $337M
over 10 fiscal years
Diluted shares, split-adjusted
95.5K84.2M168.4M2016: 37.9M shares'162017: 54.0M shares'172018: 73.2M shares'182019: 81.8M shares'192020: 90.8M shares'202021: 98.5K shares'212022: 108.9M shares'222023: 138.1M shares'232024: 152.4M shares'242025: 166.7M shares'25
Buybacks Stock-based comp
$0$25.7M$51.4M2016 buybacks: $02016 stock comp: $26.0M'162017 buybacks: $02017 stock comp: $30.5M'172018 buybacks: $02018 stock comp: $33.4M'182019 buybacks: $02019 stock comp: $51.4M'192020 buybacks: $02020 stock comp: $50.2M'202021 buybacks: $02021 stock comp: $46.9M'212022 buybacks: $02022 stock comp: $43.0M'222023 buybacks: $02023 stock comp: $32.9M'232024 buybacks: $02024 stock comp: $13.0M'242025 buybacks: $02025 stock comp: $10.3M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years37% 3–5 years52% 1–3 years3% Under 1 year8%
Quarterly turnover
14.8%
of institutional shares changed hands
Top 10 managers, median time held
4.5 years

Super Investors

Investment managers reporting HRTX on Form 13F
RC
Rubric Capital Management LP
13D · 15.9%
Shares
30.0M
% of company
15.74%
Change vs last qtr
Unchanged
Held since
2022
CC
Clearline Capital LP
Shares
11.4M
% of company
5.96%
Change vs last qtr
−851.3K (−7.0%)
Held since
2022

28 more super investors behind a free account

See every manager holding HERON THERAPEUTICS, INC. /DE/, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting HRTX on Form N-PORT; together they hold 12.9% of the company
VT
Position value
$2.34M
% of company
2.87%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$1.57M
% of company
1.93%
% of the fund
0.00%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding HERON THERAPEUTICS, INC. /DE/ and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
DR
David Rosen
5%+ holder13D · 15.9%
Shares
30.0M
% of company
15.74%
Change vs last qtr
—
Held since
—
MA
Morgan Adam
Insider
Shares
8.9M
% of company
4.65%
Change vs last qtr
—
Held since
—

10 more holders behind a free account

See every insider and 5%+ holder of HERON THERAPEUTICS, INC. /DE/.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support